nach oben

Erschienen in:

08.06.2019 | Case Report

Robotic Surgery as an Alternative Approach for Reoperation of Incidental Gallbladder Cancer

verfasst von: Raphael L. C. Araujo, Marco Aurélio de Sanctis, Tomás R. V. Coelho, Fernando E. C. Felippe, Diego Burgardt, Durval R. Wohnrath

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Laparoscopic cholecystectomy (LC) is one of the most frequently performed surgical procedures with more than a half million cholecystectomies per year in the USA [1]. Gallbladder cancer represents the sixth most common type of gastrointestinal cancer [2]. The incidental gallbladder cancer (IGBC) is diagnosed in 0.19 to 2.1% of all patients undergoing laparoscopic cholecystectomy for benign gallbladder disease [3]. Regarding the progresses in minimally invasive surgery (MIS) worldwide, LC represents one of the mainstream models of development of skills in MIS. Nowadays, robotic surgery has also been settling its place as a MIS option. …

Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut and liver. 2012;6(2):172–87.CrossRef

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRef

Konstantinidis IT, Deshpande V, Genevay M, Berger D, Fernandez-del Castillo C, Tanabe KK, et al. Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Archives of surgery (Chicago, Ill : 1960). 2009;144(5):441–7 discussion 7.CrossRef

Zhang L, Han F, Huang CS, Pang C, Han YZ, Hua YW. Analysis of the treatment of unexpected gallbladder cancer. Zhonghua wai ke za zhi [Chinese journal of surgery]. 2005;43(7):460–2.

Buell JF, Cherqui D, Geller DA, O'Rourke N, Iannitti D, Dagher I, et al. The international position on laparoscopic liver surgery: the Louisville statement, 2008. Ann Surg. 2009;250(5):825–30.CrossRef

Wakabayashi G, Cherqui D, Geller DA, Buell JF, Kaneko H, Han HS, et al. Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg. 2015;261(4):619–29.PubMed

Pawlik TM, Gleisner AL, Vigano L, Kooby DA, Bauer TW, Frilling A, et al. Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2007;11(11):1478–86; discussion 86-7.CrossRef

Goetze TO, Paolucci V. Immediate re-resection of T1 incidental gallbladder carcinomas: a survival analysis of the German Registry. Surg Endosc. 2008;22(11):2462–5.CrossRef

Fuks D, Regimbeau JM, Le Treut YP, Bachellier P, Raventos A, Pruvot FR, et al. Incidental gallbladder cancer by the AFC-GBC-2009 Study Group. World J Surg. 2011;35(8):1887–97.CrossRef

10.

Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98(7):485–9.CrossRef

Titel: Robotic Surgery as an Alternative Approach for Reoperation of Incidental Gallbladder Cancer
verfasst von: Raphael L. C. Araujo
Marco Aurélio de Sanctis
Tomás R. V. Coelho
Fernando E. C. Felippe
Diego Burgardt
Durval R. Wohnrath
Publikationsdatum: 08.06.2019
Verlag: Springer US
Erschienen in: Journal of Gastrointestinal Cancer / Ausgabe 1/2020
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-019-00264-3

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Robotic Surgery as an Alternative Approach for Reoperation of Incidental Gallbladder Cancer

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Trend of Gastric Cancer Incidence in an Area Located in the Center of Iran: 2009–2014

Dilemmas in Diagnosis and Management of Gastroenteropancreatic Mixed Neuroendocrine Non-neuroendocrine Neoplasms: First Single-Centre Report from India

Unusual and Aggressive Cause of Gall Bladder Mass—Neuroendocrine Tumor

MAEL Cancer-Testis Antigen as a Diagnostic Marker in Primary Stages of Gastric Cancer with Helicobacter pylori Infection

Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor Prognosis

Surgical Management of Bleeding Duodenal Stromal Tumours with Shock

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie